nodes	percent_of_prediction	percent_of_DWPC	metapath
Flutamide—CYP1B1—Procarbazine—brain cancer	0.534	0.694	CbGbCtD
Flutamide—CYP1A2—Carmustine—brain cancer	0.0726	0.0943	CbGbCtD
Flutamide—CYP3A4—Temozolomide—brain cancer	0.0549	0.0712	CbGbCtD
Flutamide—CYP3A4—Lomustine—brain cancer	0.0467	0.0606	CbGbCtD
Flutamide—CYP3A5—Etoposide—brain cancer	0.0289	0.0375	CbGbCtD
Flutamide—CYP1A2—Etoposide—brain cancer	0.0215	0.0279	CbGbCtD
Flutamide—CYP3A4—Etoposide—brain cancer	0.0113	0.0146	CbGbCtD
Flutamide—Metastatic neoplasm—Procarbazine—brain cancer	0.00999	0.0743	CcSEcCtD
Flutamide—Metastatic neoplasm—Hydroxyurea—brain cancer	0.00773	0.0575	CcSEcCtD
Flutamide—Metastatic neoplasm—Temozolomide—brain cancer	0.00604	0.0449	CcSEcCtD
Flutamide—Nilutamide—CYP2C9—brain cancer	0.00474	1	CrCbGaD
Flutamide—CYP1B1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00471	0.0523	CbGpPWpGaD
Flutamide—CYP1B1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00428	0.0476	CbGpPWpGaD
Flutamide—Necrolysis epidermal—Etoposide—brain cancer	0.00408	0.0304	CcSEcCtD
Flutamide—Traumatic liver injury—Temozolomide—brain cancer	0.00311	0.0231	CcSEcCtD
Flutamide—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0029	0.0322	CbGpPWpGaD
Flutamide—Neoplasm—Lomustine—brain cancer	0.00273	0.0203	CcSEcCtD
Flutamide—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00264	0.0293	CbGpPWpGaD
Flutamide—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00237	0.0263	CbGpPWpGaD
Flutamide—Neoplasm malignant—Procarbazine—brain cancer	0.00224	0.0167	CcSEcCtD
Flutamide—AR—Coregulation of Androgen receptor activity—KDM4C—brain cancer	0.00218	0.0243	CbGpPWpGaD
Flutamide—CYP1B1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00217	0.0241	CbGpPWpGaD
Flutamide—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00216	0.024	CbGpPWpGaD
Flutamide—Transaminases increased—Carmustine—brain cancer	0.00197	0.0147	CcSEcCtD
Flutamide—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00185	0.0205	CbGpPWpGaD
Flutamide—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00184	0.0204	CbGpPWpGaD
Flutamide—Gynaecomastia—Procarbazine—brain cancer	0.00171	0.0128	CcSEcCtD
Flutamide—Interstitial lung disease—Carmustine—brain cancer	0.00169	0.0126	CcSEcCtD
Flutamide—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00168	0.0187	CbGpPWpGaD
Flutamide—Interstitial lung disease—Temozolomide—brain cancer	0.00164	0.0122	CcSEcCtD
Flutamide—Ulcer—Hydroxyurea—brain cancer	0.00157	0.0117	CcSEcCtD
Flutamide—Haemolytic anaemia—Procarbazine—brain cancer	0.00154	0.0115	CcSEcCtD
Flutamide—Herpes zoster—Temozolomide—brain cancer	0.00154	0.0114	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00149	0.0165	CbGpPWpGaD
Flutamide—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00147	0.0164	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—NTRK3—brain cancer	0.00143	0.0159	CbGpPWpGaD
Flutamide—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00142	0.0157	CbGpPWpGaD
Flutamide—Blood urea increased—Hydroxyurea—brain cancer	0.0014	0.0104	CcSEcCtD
Flutamide—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00139	0.0155	CbGpPWpGaD
Flutamide—Liver injury—Temozolomide—brain cancer	0.00138	0.0102	CcSEcCtD
Flutamide—Neoplasm—Hydroxyurea—brain cancer	0.00134	0.00997	CcSEcCtD
Flutamide—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00134	0.0149	CbGpPWpGaD
Flutamide—Interstitial lung disease—Etoposide—brain cancer	0.00131	0.00974	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Procarbazine—brain cancer	0.00125	0.00932	CcSEcCtD
Flutamide—Pulmonary embolism—Carmustine—brain cancer	0.0012	0.00892	CcSEcCtD
Flutamide—Leukopenia—Lomustine—brain cancer	0.00118	0.00878	CcSEcCtD
Flutamide—Pulmonary embolism—Temozolomide—brain cancer	0.00116	0.00862	CcSEcCtD
Flutamide—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00114	0.0127	CbGpPWpGaD
Flutamide—Dermatitis bullous—Hydroxyurea—brain cancer	0.00113	0.00838	CcSEcCtD
Flutamide—Photosensitivity reaction—Procarbazine—brain cancer	0.0011	0.00816	CcSEcCtD
Flutamide—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.0011	0.0122	CbGpPWpGaD
Flutamide—CYP1B1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.00109	0.0121	CbGpPWpGaD
Flutamide—Neoplasm—Carmustine—brain cancer	0.00108	0.00806	CcSEcCtD
Flutamide—Gynaecomastia—Carmustine—brain cancer	0.00107	0.00798	CcSEcCtD
Flutamide—Drowsiness—Procarbazine—brain cancer	0.00107	0.00797	CcSEcCtD
Flutamide—Thrombocytopenia—Lomustine—brain cancer	0.00105	0.00784	CcSEcCtD
Flutamide—Neoplasm—Temozolomide—brain cancer	0.00105	0.00779	CcSEcCtD
Flutamide—Jaundice—Procarbazine—brain cancer	0.00104	0.00777	CcSEcCtD
Flutamide—Anorexia—Lomustine—brain cancer	0.00103	0.00763	CcSEcCtD
Flutamide—Haematuria—Procarbazine—brain cancer	0.00102	0.0076	CcSEcCtD
Flutamide—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00101	0.0112	CbGpPWpGaD
Flutamide—Diabetes mellitus—Carmustine—brain cancer	0.001	0.00744	CcSEcCtD
Flutamide—Ulcer—Etoposide—brain cancer	0.00098	0.00729	CcSEcCtD
Flutamide—AR—Notch-mediated HES/HEY network—HEY1—brain cancer	0.000955	0.0106	CbGpPWpGaD
Flutamide—CYP1B1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000939	0.0104	CbGpPWpGaD
Flutamide—Decreased appetite—Lomustine—brain cancer	0.000936	0.00696	CcSEcCtD
Flutamide—CYP1B1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000927	0.0103	CbGpPWpGaD
Flutamide—Hot flush—Temozolomide—brain cancer	0.000899	0.00669	CcSEcCtD
Flutamide—Menopausal symptoms—Temozolomide—brain cancer	0.000891	0.00663	CcSEcCtD
Flutamide—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000888	0.00986	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000858	0.00952	CbGpPWpGaD
Flutamide—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000854	0.00948	CbGpPWpGaD
Flutamide—AR—FOXA1 transcription factor network—SHH—brain cancer	0.000839	0.00932	CbGpPWpGaD
Flutamide—Drowsiness—Hydroxyurea—brain cancer	0.000829	0.00617	CcSEcCtD
Flutamide—Tension—Procarbazine—brain cancer	0.000822	0.00611	CcSEcCtD
Flutamide—Nervousness—Procarbazine—brain cancer	0.000813	0.00605	CcSEcCtD
Flutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000782	0.00869	CbGpPWpGaD
Flutamide—Anaemia—Procarbazine—brain cancer	0.000774	0.00576	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000772	0.00858	CbGpPWpGaD
Flutamide—CYP1B1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000761	0.00845	CbGpPWpGaD
Flutamide—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000757	0.00563	CcSEcCtD
Flutamide—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.000757	0.00563	CcSEcCtD
Flutamide—AR—Nuclear Receptors—ESR2—brain cancer	0.000755	0.00839	CbGpPWpGaD
Flutamide—Leukopenia—Procarbazine—brain cancer	0.00075	0.00558	CcSEcCtD
Flutamide—Hypertension—Procarbazine—brain cancer	0.000723	0.00538	CcSEcCtD
Flutamide—Anxiety—Procarbazine—brain cancer	0.000711	0.00529	CcSEcCtD
Flutamide—Confusional state—Procarbazine—brain cancer	0.000689	0.00513	CcSEcCtD
Flutamide—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000685	0.00761	CbGpPWpGaD
Flutamide—Vomiting—Lomustine—brain cancer	0.000685	0.00509	CcSEcCtD
Flutamide—Oedema—Procarbazine—brain cancer	0.000684	0.00508	CcSEcCtD
Flutamide—Hyperglycaemia—Carmustine—brain cancer	0.000678	0.00505	CcSEcCtD
Flutamide—Erectile dysfunction—Temozolomide—brain cancer	0.000669	0.00498	CcSEcCtD
Flutamide—Thrombocytopenia—Procarbazine—brain cancer	0.000669	0.00498	CcSEcCtD
Flutamide—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000669	0.00743	CbGpPWpGaD
Flutamide—Photosensitivity reaction—Temozolomide—brain cancer	0.000663	0.00493	CcSEcCtD
Flutamide—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000659	0.00732	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000656	0.00729	CbGpPWpGaD
Flutamide—Hyperglycaemia—Temozolomide—brain cancer	0.000656	0.00488	CcSEcCtD
Flutamide—Anorexia—Procarbazine—brain cancer	0.000652	0.00485	CcSEcCtD
Flutamide—Erythema—Hydroxyurea—brain cancer	0.000648	0.00482	CcSEcCtD
Flutamide—Nausea—Lomustine—brain cancer	0.000639	0.00476	CcSEcCtD
Flutamide—Insomnia—Procarbazine—brain cancer	0.000618	0.0046	CcSEcCtD
Flutamide—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000612	0.0068	CbGpPWpGaD
Flutamide—Somnolence—Procarbazine—brain cancer	0.000608	0.00452	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000608	0.00675	CbGpPWpGaD
Flutamide—Toxic epidermal necrolysis—Etoposide—brain cancer	0.000606	0.00451	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000604	0.00671	CbGpPWpGaD
Flutamide—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000604	0.00671	CbGpPWpGaD
Flutamide—Ill-defined disorder—Hydroxyurea—brain cancer	0.000601	0.00447	CcSEcCtD
Flutamide—Anaemia—Hydroxyurea—brain cancer	0.000599	0.00446	CcSEcCtD
Flutamide—AR—Nuclear Receptor transcription pathway—ESR2—brain cancer	0.000597	0.00663	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000596	0.00662	CbGpPWpGaD
Flutamide—Decreased appetite—Procarbazine—brain cancer	0.000594	0.00442	CcSEcCtD
Flutamide—Oedema peripheral—Carmustine—brain cancer	0.000593	0.00441	CcSEcCtD
Flutamide—AHR—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000591	0.00656	CbGpPWpGaD
Flutamide—AHR—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000591	0.00656	CbGpPWpGaD
Flutamide—Fatigue—Procarbazine—brain cancer	0.000589	0.00438	CcSEcCtD
Flutamide—Malaise—Hydroxyurea—brain cancer	0.000584	0.00435	CcSEcCtD
Flutamide—Constipation—Procarbazine—brain cancer	0.000584	0.00435	CcSEcCtD
Flutamide—Hepatitis—Temozolomide—brain cancer	0.000582	0.00433	CcSEcCtD
Flutamide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000581	0.00645	CbGpPWpGaD
Flutamide—Leukopenia—Hydroxyurea—brain cancer	0.00058	0.00432	CcSEcCtD
Flutamide—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000578	0.00642	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—HES5—brain cancer	0.000573	0.00637	CbGpPWpGaD
Flutamide—Oedema peripheral—Temozolomide—brain cancer	0.000573	0.00426	CcSEcCtD
Flutamide—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000571	0.00634	CbGpPWpGaD
Flutamide—Feeling abnormal—Procarbazine—brain cancer	0.000563	0.00419	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000548	0.00408	CcSEcCtD
Flutamide—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000547	0.00608	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CDK6—brain cancer	0.000546	0.00606	CbGpPWpGaD
Flutamide—Discomfort—Hydroxyurea—brain cancer	0.000545	0.00406	CcSEcCtD
Flutamide—AHR—Adipogenesis—IRS2—brain cancer	0.000541	0.00601	CbGpPWpGaD
Flutamide—Oedema—Hydroxyurea—brain cancer	0.000529	0.00394	CcSEcCtD
Flutamide—Erythema—Carmustine—brain cancer	0.000524	0.0039	CcSEcCtD
Flutamide—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.00052	0.00577	CbGpPWpGaD
Flutamide—Thrombocytopenia—Hydroxyurea—brain cancer	0.000518	0.00385	CcSEcCtD
Flutamide—Skin disorder—Hydroxyurea—brain cancer	0.000514	0.00382	CcSEcCtD
Flutamide—Erythema—Temozolomide—brain cancer	0.000506	0.00377	CcSEcCtD
Flutamide—Jaundice—Etoposide—brain cancer	0.000505	0.00376	CcSEcCtD
Flutamide—Anorexia—Hydroxyurea—brain cancer	0.000504	0.00375	CcSEcCtD
Flutamide—CYP1B1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000501	0.00556	CbGpPWpGaD
Flutamide—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000496	0.00551	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—HES1—brain cancer	0.000495	0.00549	CbGpPWpGaD
Flutamide—Asthenia—Procarbazine—brain cancer	0.00049	0.00365	CcSEcCtD
Flutamide—Anaemia—Carmustine—brain cancer	0.000484	0.0036	CcSEcCtD
Flutamide—Pruritus—Procarbazine—brain cancer	0.000484	0.0036	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—SIRT1—brain cancer	0.000474	0.00526	CbGpPWpGaD
Flutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000473	0.00525	CbGpPWpGaD
Flutamide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00047	0.00522	CbGpPWpGaD
Flutamide—Somnolence—Hydroxyurea—brain cancer	0.00047	0.0035	CcSEcCtD
Flutamide—Ill-defined disorder—Temozolomide—brain cancer	0.00047	0.00349	CcSEcCtD
Flutamide—Leukopenia—Carmustine—brain cancer	0.000469	0.00349	CcSEcCtD
Flutamide—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000469	0.0052	CbGpPWpGaD
Flutamide—Anaemia—Temozolomide—brain cancer	0.000468	0.00348	CcSEcCtD
Flutamide—Diarrhoea—Procarbazine—brain cancer	0.000468	0.00348	CcSEcCtD
Flutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000467	0.00518	CbGpPWpGaD
Flutamide—AR—Regulation of Androgen receptor activity—SIRT1—brain cancer	0.000466	0.00518	CbGpPWpGaD
Flutamide—Decreased appetite—Hydroxyurea—brain cancer	0.00046	0.00342	CcSEcCtD
Flutamide—Malaise—Temozolomide—brain cancer	0.000457	0.0034	CcSEcCtD
Flutamide—Fatigue—Hydroxyurea—brain cancer	0.000456	0.00339	CcSEcCtD
Flutamide—Leukopenia—Temozolomide—brain cancer	0.000453	0.00337	CcSEcCtD
Flutamide—Hypertension—Carmustine—brain cancer	0.000452	0.00337	CcSEcCtD
Flutamide—Constipation—Hydroxyurea—brain cancer	0.000452	0.00337	CcSEcCtD
Flutamide—Dizziness—Procarbazine—brain cancer	0.000452	0.00336	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000451	0.005	CbGpPWpGaD
Flutamide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000448	0.00498	CbGpPWpGaD
Flutamide—Anxiety—Carmustine—brain cancer	0.000445	0.00331	CcSEcCtD
Flutamide—Hypertension—Temozolomide—brain cancer	0.000437	0.00325	CcSEcCtD
Flutamide—Feeling abnormal—Hydroxyurea—brain cancer	0.000436	0.00324	CcSEcCtD
Flutamide—Vomiting—Procarbazine—brain cancer	0.000435	0.00323	CcSEcCtD
Flutamide—Confusional state—Carmustine—brain cancer	0.000431	0.00321	CcSEcCtD
Flutamide—Rash—Procarbazine—brain cancer	0.000431	0.00321	CcSEcCtD
Flutamide—Dermatitis—Procarbazine—brain cancer	0.000431	0.0032	CcSEcCtD
Flutamide—Anxiety—Temozolomide—brain cancer	0.00043	0.0032	CcSEcCtD
Flutamide—Headache—Procarbazine—brain cancer	0.000428	0.00319	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000428	0.00318	CcSEcCtD
Flutamide—Oedema—Carmustine—brain cancer	0.000428	0.00318	CcSEcCtD
Flutamide—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000427	0.00474	CbGpPWpGaD
Flutamide—Discomfort—Temozolomide—brain cancer	0.000426	0.00317	CcSEcCtD
Flutamide—Thrombocytopenia—Carmustine—brain cancer	0.000419	0.00311	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000417	0.00463	CbGpPWpGaD
Flutamide—Confusional state—Temozolomide—brain cancer	0.000417	0.0031	CcSEcCtD
Flutamide—Oedema—Temozolomide—brain cancer	0.000413	0.00307	CcSEcCtD
Flutamide—Anorexia—Carmustine—brain cancer	0.000408	0.00303	CcSEcCtD
Flutamide—Nausea—Procarbazine—brain cancer	0.000406	0.00302	CcSEcCtD
Flutamide—Thrombocytopenia—Temozolomide—brain cancer	0.000405	0.00301	CcSEcCtD
Flutamide—CYP1B1—Biological oxidations—CYP2C9—brain cancer	0.000404	0.00449	CbGpPWpGaD
Flutamide—Skin disorder—Temozolomide—brain cancer	0.000401	0.00299	CcSEcCtD
Flutamide—CYP1B1—Metapathway biotransformation—CYP2C9—brain cancer	0.000399	0.00443	CbGpPWpGaD
Flutamide—Anorexia—Temozolomide—brain cancer	0.000394	0.00293	CcSEcCtD
Flutamide—Insomnia—Carmustine—brain cancer	0.000387	0.00288	CcSEcCtD
Flutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000384	0.00426	CbGpPWpGaD
Flutamide—Somnolence—Carmustine—brain cancer	0.00038	0.00283	CcSEcCtD
Flutamide—Asthenia—Hydroxyurea—brain cancer	0.00038	0.00282	CcSEcCtD
Flutamide—Ill-defined disorder—Etoposide—brain cancer	0.000376	0.0028	CcSEcCtD
Flutamide—Anaemia—Etoposide—brain cancer	0.000374	0.00279	CcSEcCtD
Flutamide—Insomnia—Temozolomide—brain cancer	0.000374	0.00278	CcSEcCtD
Flutamide—Decreased appetite—Carmustine—brain cancer	0.000372	0.00277	CcSEcCtD
Flutamide—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000369	0.00409	CbGpPWpGaD
Flutamide—Somnolence—Temozolomide—brain cancer	0.000367	0.00273	CcSEcCtD
Flutamide—Constipation—Carmustine—brain cancer	0.000366	0.00272	CcSEcCtD
Flutamide—Malaise—Etoposide—brain cancer	0.000365	0.00272	CcSEcCtD
Flutamide—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000364	0.00404	CbGpPWpGaD
Flutamide—Leukopenia—Etoposide—brain cancer	0.000363	0.0027	CcSEcCtD
Flutamide—Diarrhoea—Hydroxyurea—brain cancer	0.000362	0.00269	CcSEcCtD
Flutamide—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000361	0.00401	CbGpPWpGaD
Flutamide—Decreased appetite—Temozolomide—brain cancer	0.000359	0.00267	CcSEcCtD
Flutamide—AHR—Circadian rythm related genes—CDK4—brain cancer	0.000358	0.00398	CbGpPWpGaD
Flutamide—Fatigue—Temozolomide—brain cancer	0.000356	0.00265	CcSEcCtD
Flutamide—Constipation—Temozolomide—brain cancer	0.000353	0.00263	CcSEcCtD
Flutamide—Feeling abnormal—Carmustine—brain cancer	0.000352	0.00262	CcSEcCtD
Flutamide—Hypertension—Etoposide—brain cancer	0.00035	0.0026	CcSEcCtD
Flutamide—Dizziness—Hydroxyurea—brain cancer	0.00035	0.0026	CcSEcCtD
Flutamide—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000343	0.00255	CcSEcCtD
Flutamide—Discomfort—Etoposide—brain cancer	0.000341	0.00254	CcSEcCtD
Flutamide—Feeling abnormal—Temozolomide—brain cancer	0.000341	0.00253	CcSEcCtD
Flutamide—Vomiting—Hydroxyurea—brain cancer	0.000336	0.0025	CcSEcCtD
Flutamide—Rash—Hydroxyurea—brain cancer	0.000334	0.00248	CcSEcCtD
Flutamide—Confusional state—Etoposide—brain cancer	0.000333	0.00248	CcSEcCtD
Flutamide—Dermatitis—Hydroxyurea—brain cancer	0.000333	0.00248	CcSEcCtD
Flutamide—Headache—Hydroxyurea—brain cancer	0.000331	0.00247	CcSEcCtD
Flutamide—AHR—Adipogenesis—CTNNB1—brain cancer	0.000325	0.00361	CbGpPWpGaD
Flutamide—Thrombocytopenia—Etoposide—brain cancer	0.000324	0.00241	CcSEcCtD
Flutamide—Skin disorder—Etoposide—brain cancer	0.000321	0.00239	CcSEcCtD
Flutamide—Anorexia—Etoposide—brain cancer	0.000315	0.00234	CcSEcCtD
Flutamide—Nausea—Hydroxyurea—brain cancer	0.000314	0.00234	CcSEcCtD
Flutamide—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000309	0.00343	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—SIRT1—brain cancer	0.000308	0.00342	CbGpPWpGaD
Flutamide—Asthenia—Carmustine—brain cancer	0.000307	0.00228	CcSEcCtD
Flutamide—AR—Androgen receptor signaling pathway—CCNE1—brain cancer	0.000304	0.00338	CbGpPWpGaD
Flutamide—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000299	0.00332	CbGpPWpGaD
Flutamide—Asthenia—Temozolomide—brain cancer	0.000296	0.00221	CcSEcCtD
Flutamide—Somnolence—Etoposide—brain cancer	0.000294	0.00219	CcSEcCtD
Flutamide—Diarrhoea—Carmustine—brain cancer	0.000293	0.00218	CcSEcCtD
Flutamide—Pruritus—Temozolomide—brain cancer	0.000292	0.00217	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—CCND1—brain cancer	0.000291	0.00323	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	0.000288	0.0032	CbGpPWpGaD
Flutamide—Decreased appetite—Etoposide—brain cancer	0.000287	0.00214	CcSEcCtD
Flutamide—Fatigue—Etoposide—brain cancer	0.000285	0.00212	CcSEcCtD
Flutamide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000285	0.00316	CbGpPWpGaD
Flutamide—AHR—Adipogenesis—STAT3—brain cancer	0.000283	0.00314	CbGpPWpGaD
Flutamide—Dizziness—Carmustine—brain cancer	0.000283	0.0021	CcSEcCtD
Flutamide—Constipation—Etoposide—brain cancer	0.000283	0.0021	CcSEcCtD
Flutamide—Diarrhoea—Temozolomide—brain cancer	0.000283	0.0021	CcSEcCtD
Flutamide—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000281	0.00312	CbGpPWpGaD
Flutamide—Dizziness—Temozolomide—brain cancer	0.000273	0.00203	CcSEcCtD
Flutamide—Feeling abnormal—Etoposide—brain cancer	0.000272	0.00203	CcSEcCtD
Flutamide—Vomiting—Carmustine—brain cancer	0.000272	0.00202	CcSEcCtD
Flutamide—Rash—Carmustine—brain cancer	0.00027	0.00201	CcSEcCtD
Flutamide—Dermatitis—Carmustine—brain cancer	0.000269	0.002	CcSEcCtD
Flutamide—Headache—Carmustine—brain cancer	0.000268	0.00199	CcSEcCtD
Flutamide—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000264	0.00293	CbGpPWpGaD
Flutamide—Vomiting—Temozolomide—brain cancer	0.000263	0.00195	CcSEcCtD
Flutamide—Rash—Temozolomide—brain cancer	0.000261	0.00194	CcSEcCtD
Flutamide—Dermatitis—Temozolomide—brain cancer	0.00026	0.00194	CcSEcCtD
Flutamide—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.00026	0.00289	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000259	0.00288	CbGpPWpGaD
Flutamide—Headache—Temozolomide—brain cancer	0.000259	0.00193	CcSEcCtD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000257	0.00285	CbGpPWpGaD
Flutamide—Nausea—Carmustine—brain cancer	0.000254	0.00189	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000254	0.00282	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—brain cancer	0.000251	0.00279	CbGpPWpGaD
Flutamide—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000249	0.00276	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000246	0.00273	CbGpPWpGaD
Flutamide—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000246	0.00273	CbGpPWpGaD
Flutamide—Nausea—Temozolomide—brain cancer	0.000245	0.00183	CcSEcCtD
Flutamide—AR—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000244	0.00271	CbGpPWpGaD
Flutamide—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000242	0.00268	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—brain cancer	0.000241	0.00267	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000241	0.00267	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—APC—brain cancer	0.000239	0.00265	CbGpPWpGaD
Flutamide—Asthenia—Etoposide—brain cancer	0.000237	0.00176	CcSEcCtD
Flutamide—Pruritus—Etoposide—brain cancer	0.000234	0.00174	CcSEcCtD
Flutamide—AHR—Integrated Breast Cancer Pathway—MYC—brain cancer	0.000233	0.00259	CbGpPWpGaD
Flutamide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000231	0.00256	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—EGFR—brain cancer	0.000228	0.00253	CbGpPWpGaD
Flutamide—Diarrhoea—Etoposide—brain cancer	0.000226	0.00168	CcSEcCtD
Flutamide—Dizziness—Etoposide—brain cancer	0.000219	0.00163	CcSEcCtD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000217	0.00241	CbGpPWpGaD
Flutamide—AR—Notch-mediated HES/HEY network—STAT3—brain cancer	0.000216	0.0024	CbGpPWpGaD
Flutamide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000214	0.00238	CbGpPWpGaD
Flutamide—Vomiting—Etoposide—brain cancer	0.00021	0.00156	CcSEcCtD
Flutamide—Rash—Etoposide—brain cancer	0.000208	0.00155	CcSEcCtD
Flutamide—Dermatitis—Etoposide—brain cancer	0.000208	0.00155	CcSEcCtD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.000208	0.0023	CbGpPWpGaD
Flutamide—Headache—Etoposide—brain cancer	0.000207	0.00154	CcSEcCtD
Flutamide—AR—Integrated Breast Cancer Pathway—BRCA2—brain cancer	0.000206	0.00228	CbGpPWpGaD
Flutamide—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000204	0.00226	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CCND1—brain cancer	0.000203	0.00226	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—SIRT1—brain cancer	0.000202	0.00224	CbGpPWpGaD
Flutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—brain cancer	0.000201	0.00224	CbGpPWpGaD
Flutamide—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.000201	0.00223	CbGpPWpGaD
Flutamide—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000197	0.00218	CbGpPWpGaD
Flutamide—Nausea—Etoposide—brain cancer	0.000196	0.00146	CcSEcCtD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—brain cancer	0.000194	0.00215	CbGpPWpGaD
Flutamide—AHR—Integrated Breast Cancer Pathway—TP53—brain cancer	0.000192	0.00213	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—HES1—brain cancer	0.000189	0.0021	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000184	0.00204	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—RELA—brain cancer	0.000171	0.0019	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.00017	0.00189	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000169	0.00188	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.000167	0.00186	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000166	0.00184	CbGpPWpGaD
Flutamide—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000166	0.00184	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000165	0.00183	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000164	0.00182	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CCND1—brain cancer	0.000164	0.00182	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—brain cancer	0.000162	0.0018	CbGpPWpGaD
Flutamide—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000159	0.00176	CbGpPWpGaD
Flutamide—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000157	0.00174	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000155	0.00172	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.000153	0.0017	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.000153	0.00169	CbGpPWpGaD
Flutamide—AHR—Circadian rythm related genes—TP53—brain cancer	0.000152	0.00169	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CCND1—brain cancer	0.00015	0.00167	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—CTNNB1—brain cancer	0.000149	0.00165	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000148	0.00165	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000146	0.00162	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000133	0.00148	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MYC—brain cancer	0.000131	0.00146	CbGpPWpGaD
Flutamide—AR—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	0.00013	0.00144	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—STAT3—brain cancer	0.00013	0.00144	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000126	0.0014	CbGpPWpGaD
Flutamide—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000123	0.00136	CbGpPWpGaD
Flutamide—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000121	0.00134	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000119	0.00132	CbGpPWpGaD
Flutamide—AR—Androgen receptor signaling pathway—EGFR—brain cancer	0.000118	0.00131	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	0.000114	0.00126	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000113	0.00126	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000104	0.00116	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—ESR2—brain cancer	0.000103	0.00114	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000102	0.00113	CbGpPWpGaD
Flutamide—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000102	0.00113	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CCND1—brain cancer	9.85e-05	0.00109	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—NOTCH2—brain cancer	9.76e-05	0.00108	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	9.75e-05	0.00108	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.56e-05	0.00106	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—CTNNB1—brain cancer	9.5e-05	0.00106	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.45e-05	0.00105	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	9.24e-05	0.00103	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—VEGFA—brain cancer	8.59e-05	0.000953	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	8.51e-05	0.000945	CbGpPWpGaD
Flutamide—AR—SIDS Susceptibility Pathways—VEGFA—brain cancer	8.37e-05	0.000929	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	8.16e-05	0.000906	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	8.08e-05	0.000897	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—MYC—brain cancer	7.9e-05	0.000877	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.82e-05	0.000869	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—EGFR—brain cancer	7.73e-05	0.000858	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.23e-05	0.000803	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	7.11e-05	0.00079	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.99e-05	0.000776	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—CYP2C9—brain cancer	6.91e-05	0.000768	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.65e-05	0.000739	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	6.55e-05	0.000727	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.51e-05	0.000723	CbGpPWpGaD
Flutamide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.51e-05	0.000723	CbGpPWpGaD
Flutamide—AR—Integrated Breast Cancer Pathway—TP53—brain cancer	6.49e-05	0.00072	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	6.4e-05	0.000711	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.1e-05	0.000677	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—BSG—brain cancer	5.88e-05	0.000653	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.72e-05	0.000635	CbGpPWpGaD
Flutamide—AR—Gene Expression—DNMT1—brain cancer	5.53e-05	0.000614	CbGpPWpGaD
Flutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	5.38e-05	0.000597	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—IDH1—brain cancer	5.06e-05	0.000561	CbGpPWpGaD
Flutamide—AR—Gene Expression—ESR2—brain cancer	4.96e-05	0.000551	CbGpPWpGaD
Flutamide—AR—Gene Expression—NOTCH2—brain cancer	4.7e-05	0.000522	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—CYP2C9—brain cancer	4.51e-05	0.0005	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.46e-05	0.000495	CbGpPWpGaD
Flutamide—AHR—telencephalon—brain cancer	4.43e-05	0.0758	CbGeAlD
Flutamide—CYP1A1—Metabolism—CYP2C9—brain cancer	4.26e-05	0.000473	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.12e-05	0.000457	CbGpPWpGaD
Flutamide—AR—Gene Expression—SIRT1—brain cancer	4e-05	0.000444	CbGpPWpGaD
Flutamide—CYP1B1—Metabolism—ENO2—brain cancer	4e-05	0.000444	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—BSG—brain cancer	3.83e-05	0.000426	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—BSG—brain cancer	3.62e-05	0.000402	CbGpPWpGaD
Flutamide—AHR—pituitary gland—brain cancer	3.61e-05	0.0617	CbGeAlD
Flutamide—AHR—medulla oblongata—brain cancer	3.48e-05	0.0595	CbGeAlD
Flutamide—CYP2C19—Metabolism—CYP2C9—brain cancer	3.48e-05	0.000387	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—IDH1—brain cancer	3.3e-05	0.000366	CbGpPWpGaD
Flutamide—AR—Generic Transcription Pathway—MYC—brain cancer	3.25e-05	0.000361	CbGpPWpGaD
Flutamide—AHR—midbrain—brain cancer	3.18e-05	0.0544	CbGeAlD
Flutamide—CYP1A1—Metabolism—IDH1—brain cancer	3.11e-05	0.000346	CbGpPWpGaD
Flutamide—AHR—spinal cord—brain cancer	3.11e-05	0.0531	CbGeAlD
Flutamide—CYP2C19—Metabolism—BSG—brain cancer	2.96e-05	0.000329	CbGpPWpGaD
Flutamide—AHR—endocrine gland—brain cancer	2.8e-05	0.0478	CbGeAlD
Flutamide—CYP1A2—Metabolism—CYP2C9—brain cancer	2.71e-05	0.000301	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—ENO2—brain cancer	2.6e-05	0.000289	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—IDH1—brain cancer	2.55e-05	0.000283	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.54e-05	0.000281	CbGpPWpGaD
Flutamide—AHR—cerebellum—brain cancer	2.46e-05	0.0421	CbGeAlD
Flutamide—CYP1A1—Metabolism—ENO2—brain cancer	2.46e-05	0.000273	CbGpPWpGaD
Flutamide—CYP1B1—telencephalon—brain cancer	2.31e-05	0.0395	CbGeAlD
Flutamide—CYP1A2—Metabolism—BSG—brain cancer	2.31e-05	0.000256	CbGpPWpGaD
Flutamide—AR—telencephalon—brain cancer	2.19e-05	0.0374	CbGeAlD
Flutamide—CYP3A4—Metabolism—CYP2C9—brain cancer	2.1e-05	0.000233	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.07e-05	0.00023	CbGpPWpGaD
Flutamide—CYP2C19—Metabolism—ENO2—brain cancer	2.01e-05	0.000224	CbGpPWpGaD
Flutamide—AHR—brain—brain cancer	2e-05	0.0342	CbGeAlD
Flutamide—CYP1A2—Metabolism—IDH1—brain cancer	1.99e-05	0.00022	CbGpPWpGaD
Flutamide—CYP1B1—gonad—brain cancer	1.93e-05	0.0329	CbGeAlD
Flutamide—CYP1B1—pituitary gland—brain cancer	1.88e-05	0.0321	CbGeAlD
Flutamide—CYP1B1—Metabolism—PIK3CG—brain cancer	1.83e-05	0.000204	CbGpPWpGaD
Flutamide—AR—gonad—brain cancer	1.83e-05	0.0312	CbGeAlD
Flutamide—CYP3A4—Metabolism—BSG—brain cancer	1.78e-05	0.000198	CbGpPWpGaD
Flutamide—AR—pituitary gland—brain cancer	1.78e-05	0.0304	CbGeAlD
Flutamide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.62e-05	0.000179	CbGpPWpGaD
Flutamide—CYP1A2—Metabolism—ENO2—brain cancer	1.57e-05	0.000174	CbGpPWpGaD
Flutamide—AR—Gene Expression—MYC—brain cancer	1.57e-05	0.000174	CbGpPWpGaD
Flutamide—AR—spinal cord—brain cancer	1.53e-05	0.0262	CbGeAlD
Flutamide—CYP3A4—Metabolism—IDH1—brain cancer	1.53e-05	0.00017	CbGpPWpGaD
Flutamide—CYP1B1—endocrine gland—brain cancer	1.46e-05	0.0249	CbGeAlD
Flutamide—CYP1B1—head—brain cancer	1.44e-05	0.0246	CbGeAlD
Flutamide—AR—endocrine gland—brain cancer	1.38e-05	0.0236	CbGeAlD
Flutamide—AR—head—brain cancer	1.36e-05	0.0233	CbGeAlD
Flutamide—CYP1B1—central nervous system—brain cancer	1.31e-05	0.0224	CbGeAlD
Flutamide—CYP1B1—cerebellum—brain cancer	1.28e-05	0.0219	CbGeAlD
Flutamide—CYP2C19—endocrine gland—brain cancer	1.28e-05	0.0218	CbGeAlD
Flutamide—AR—central nervous system—brain cancer	1.24e-05	0.0212	CbGeAlD
Flutamide—CYP3A4—Metabolism—ENO2—brain cancer	1.21e-05	0.000134	CbGpPWpGaD
Flutamide—CYP3A5—Metabolism—PIK3CG—brain cancer	1.19e-05	0.000133	CbGpPWpGaD
Flutamide—CYP1A1—Metabolism—PIK3CG—brain cancer	1.13e-05	0.000125	CbGpPWpGaD
Flutamide—CYP1A2—endocrine gland—brain cancer	1.04e-05	0.0178	CbGeAlD
Flutamide—CYP1B1—brain—brain cancer	1.04e-05	0.0178	CbGeAlD
Flutamide—CYP1A1—endocrine gland—brain cancer	1.03e-05	0.0176	CbGeAlD
Flutamide—CYP1A1—head—brain cancer	1.02e-05	0.0174	CbGeAlD
Flutamide—CYP3A5—endocrine gland—brain cancer	1.01e-05	0.0172	CbGeAlD
Flutamide—AR—brain—brain cancer	9.87e-06	0.0169	CbGeAlD
Flutamide—CYP1A1—central nervous system—brain cancer	9.28e-06	0.0159	CbGeAlD
Flutamide—CYP2C19—Metabolism—PIK3CG—brain cancer	9.24e-06	0.000103	CbGpPWpGaD
Flutamide—CYP3A4—endocrine gland—brain cancer	7.56e-06	0.0129	CbGeAlD
Flutamide—CYP1A1—brain—brain cancer	7.37e-06	0.0126	CbGeAlD
Flutamide—CYP1A2—Metabolism—PIK3CG—brain cancer	7.2e-06	7.99e-05	CbGpPWpGaD
Flutamide—CYP3A4—central nervous system—brain cancer	6.81e-06	0.0116	CbGeAlD
Flutamide—CYP3A4—Metabolism—PIK3CG—brain cancer	5.56e-06	6.17e-05	CbGpPWpGaD
